KR890001487B1 - 푸린 유도체의 제조방법 - Google Patents

푸린 유도체의 제조방법 Download PDF

Info

Publication number
KR890001487B1
KR890001487B1 KR1019830004845A KR830004845A KR890001487B1 KR 890001487 B1 KR890001487 B1 KR 890001487B1 KR 1019830004845 A KR1019830004845 A KR 1019830004845A KR 830004845 A KR830004845 A KR 830004845A KR 890001487 B1 KR890001487 B1 KR 890001487B1
Authority
KR
South Korea
Prior art keywords
group
compound
amino
purine
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830004845A
Other languages
English (en)
Korean (ko)
Other versions
KR840006483A (ko
Inventor
존 쉐퍼 하워드
안토니 크레니쯔키 토마스
마리 뷰우챔프 릴리아
Original Assignee
더 웰컴 파운데이숀 리미티드
엠.피.잭슨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/434,384 external-priority patent/US4544634A/en
Priority claimed from US06/434,395 external-priority patent/US4609662A/en
Priority claimed from GB838320309A external-priority patent/GB8320309D0/en
Application filed by 더 웰컴 파운데이숀 리미티드, 엠.피.잭슨 filed Critical 더 웰컴 파운데이숀 리미티드
Publication of KR840006483A publication Critical patent/KR840006483A/ko
Application granted granted Critical
Publication of KR890001487B1 publication Critical patent/KR890001487B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019830004845A 1982-10-14 1983-10-13 푸린 유도체의 제조방법 Expired KR890001487B1 (ko)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US43439482A 1982-10-14 1982-10-14
US43439382A 1982-10-14 1982-10-14
US434394 1982-10-14
US06/434,384 US4544634A (en) 1982-10-14 1982-10-14 Method of producing acyclovir
US434384 1982-10-14
US06/434,395 US4609662A (en) 1982-10-14 1982-10-14 Method for using purine derivatives
US434393 1982-10-14
US434395 1982-10-14
GB838320309A GB8320309D0 (en) 1983-07-28 1983-07-28 Antiviral compounds
GB832030P 1983-07-28

Publications (2)

Publication Number Publication Date
KR840006483A KR840006483A (ko) 1984-11-30
KR890001487B1 true KR890001487B1 (ko) 1989-05-04

Family

ID=27516520

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830004845A Expired KR890001487B1 (ko) 1982-10-14 1983-10-13 푸린 유도체의 제조방법

Country Status (19)

Country Link
EP (2) EP0158847B1 (enExample)
JP (1) JPS5989682A (enExample)
KR (1) KR890001487B1 (enExample)
AT (2) ATE33654T1 (enExample)
AU (1) AU573540B2 (enExample)
CA (1) CA1308714C (enExample)
CS (1) CS244697B2 (enExample)
DE (2) DE3376325D1 (enExample)
DK (1) DK472683A (enExample)
FI (1) FI74468C (enExample)
GB (2) GB2130204B (enExample)
GR (1) GR79681B (enExample)
IE (1) IE56416B1 (enExample)
MC (1) MC1551A1 (enExample)
NO (1) NO161116C (enExample)
NZ (1) NZ205955A (enExample)
PL (1) PL143208B1 (enExample)
PT (2) PT77494B (enExample)
ZW (1) ZW22283A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US5250688A (en) * 1984-09-20 1993-10-05 Beecham Group P.L.C. Purine derivatives
DK163985A (da) * 1984-04-13 1985-10-14 Wellcome Found Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
DE3667058D1 (en) * 1985-05-02 1989-12-28 Wellcome Found Antiviral compounds
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3627024A1 (de) 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
MY101126A (en) * 1985-12-13 1991-07-31 Beecham Group Plc Novel compounds
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
ATE72122T1 (de) * 1987-04-24 1992-02-15 Wellcome Found Antivirale mischungen.
EP0289992B1 (en) * 1987-05-04 1994-04-27 Kemijski Institut Process for preparing purine derivates
GB8713695D0 (en) * 1987-06-11 1987-07-15 Beecham Group Plc Process
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
US5284837A (en) * 1988-05-06 1994-02-08 Medivir Ab Derivatives of purine, process for their preparation and a pharmaceutical preparation
EP0363320A3 (de) * 1988-10-06 1991-11-21 Ciba-Geigy Ag Substituierte 9H-Purine
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
DE10299039I1 (de) * 1988-12-19 2003-02-20 Wellcome Found Antivirale Pyrimidin- und Purinverbindungen Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Praeparte
DE3941658A1 (de) * 1989-12-16 1991-06-20 Hoechst Ag Verfahren zur herstellung von 2-acylamino-9-acyl-6-halogen-purin
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
PL143974B1 (en) * 1982-02-01 1988-03-31 Syntex Inc Method of obtaining novel 9-/1,3-diacyloxy-2-propoxymethyl/-purines
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents

Also Published As

Publication number Publication date
GR79681B (enExample) 1984-10-31
GB2151222A (en) 1985-07-17
FI833730L (fi) 1984-04-15
DE3376325D1 (en) 1988-05-26
PT79813A (en) 1985-02-01
GB2130204A (en) 1984-05-31
FI833730A0 (fi) 1983-10-13
EP0108285A2 (en) 1984-05-16
ZW22283A1 (en) 1985-05-22
GB8327513D0 (en) 1983-11-16
DE3376326D1 (en) 1988-05-26
ATE33653T1 (de) 1988-05-15
PL244141A1 (en) 1985-06-18
JPS5989682A (ja) 1984-05-23
DK472683A (da) 1984-04-15
EP0158847A1 (en) 1985-10-23
JPH0549674B2 (enExample) 1993-07-26
GB2130204B (en) 1986-03-05
GB2151222B (en) 1987-02-25
EP0108285A3 (en) 1985-05-15
NO161116B (no) 1989-03-28
AU2016383A (en) 1984-04-19
NO833722L (no) 1984-04-16
PL143208B1 (en) 1988-01-30
EP0108285B1 (en) 1988-04-20
MC1551A1 (fr) 1984-08-31
KR840006483A (ko) 1984-11-30
FI74468B (fi) 1987-10-30
GB8421849D0 (en) 1984-10-03
IE832409L (en) 1984-04-14
IE56416B1 (en) 1991-07-31
DK472683D0 (da) 1983-10-13
EP0158847B1 (en) 1988-04-20
CA1308714C (en) 1992-10-13
ATE33654T1 (de) 1988-05-15
CS244697B2 (en) 1986-08-14
PT77494A (en) 1983-11-01
NO161116C (no) 1989-07-05
AU573540B2 (en) 1988-06-16
PT77494B (en) 1986-08-14
FI74468C (fi) 1988-02-08
PT79813B (en) 1986-10-28
NZ205955A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
KR890001487B1 (ko) 푸린 유도체의 제조방법
KR880002276B1 (ko) 항비루스성 화합물의 제조방법
US4714701A (en) Antiviral compounds
FI89713C (fi) Foerfarande foer framstaellning av terapeutiskt aktivt 2-(2-amino-1,6-dihydro-6-oxo-9h(purin-9-yl)metoxi)etyl-l-valinat eller l-isoleucinat eller deras salt
AU697107B2 (en) 2-(2-amino-1,6-dihydro-6-oxopurin-9-yl)methoxy-1,3- propanediol derivative
EP2041135A1 (en) 8-oxoadenine derivatives acting as modulators of tlr7
US4609662A (en) Method for using purine derivatives
US4544634A (en) Method of producing acyclovir
JP2791116B2 (ja) 治療用化合物
EP0366385B1 (en) Guanine derivatives having antiviral activity and their pharmaceutically acceptable salts
US4695570A (en) Antiviral compound use
US4649140A (en) Purine derivatives
US5059604A (en) 2-amino purine derivatives
US4745119A (en) Method for using purine derivatives
KR20000006339A (ko) 아라비노실아데닌유도체
US5126347A (en) Isomeric dideoxynuclesides
IE44708B1 (en) Esters of hydroxyalkoxylkyl purines, their preparation, and pharmaceutical compositions containing them
CA1287050C (en) Antiviral purine derivatives
FI76088B (fi) Foerfarande foer framstaellning av antivirala purinderivat.
EP0158513A2 (en) Antiviral compounds
GB1561380A (en) Esters of hydroxyalkoxyalkyl purines their preparation and pharmaceutical compositions containing them
NZ217312A (en) Purine derivatives and pharmaceutical compositions
EP0203736A1 (en) Antiviral compounds
HU193273B (en) Process for producing antiviral 6-deoxy-acyclovir and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19920505

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19920505